15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Fortress Biotech Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $17.00 to $17.00, so the covering firms are broadly aligned. The average target of $17.00 sits 530% above the current $2.70. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.25 next quarter toward $-1.00 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Strong Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Fortress Biotech Inc.
As of Sep, 1 of 1 firms rate FBIO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
FBIO EPS & revenue forecast
EPS · NEXT QUARTER
$-0.25
Range $-0.25 – $-0.25 · 1 analysts · +19% YoY
Next period, 1 analysts expect Fortress Biotech Inc to earn $-0.25 a share (range $-0.25 – $-0.25), versus $-0.21 a year earlier. Full-year consensus is $2.55, growing to $-1.00 the year after.
REVENUE · NEXT QUARTER
$22.5M
Range $22.5M – $22.5M · 1 analysts · +40% YoY
Revenue is expected to reach $22.5M (range $22.5M – $22.5M), +39.7% year-over-year. Full-year consensus is $78.8M, rising to $113.3M next year.
Top analysts covering Fortress Biotech Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on FBIO.
#1
Joseph Pantginis
HC Wainwright & Co. · Rank #291
Buy
$17.00+529.6% to target
Overall win rate
34%
+ Follow
#2
JW
Jason Wittes
Roth MKM · Rank #311
Buy
$12.00+344.4% to target
Overall win rate
39%
+ Follow
#3
SH
Scott Henry
Alliance Global Partners
Buy
$5.00+85.2% to target
Coverage
—
+ Follow
FBIO stock forecast FAQ
What is FBIO's average 12-month price target?+
The 1 analysts with a live target average $17.00 for Fortress Biotech Inc over the next 12 months, ranging from a $17.00 high to a $17.00 low.
Is FBIO stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover FBIO?+
1 analysts have an active rating on Fortress Biotech Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering FBIO?+
Among analysts who currently cover FBIO, Joseph Pantginis of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #291). Their current call is Buy with a $17.00 target.
What is Fortress Biotech Inc's projected EPS for next quarter?+
The consensus estimate is $-0.25 per share (range $-0.25 – $-0.25) across 1 analysts. Full-year EPS is projected at $2.55, rising to $-1.00 the following year.
How much revenue is Fortress Biotech Inc expected to report next quarter?+
Consensus revenue is $22.5M (range $22.5M – $22.5M). Full-year revenue is projected at $78.8M, growing to $113.3M next year.
Have analysts been upgrading or downgrading FBIO lately?+
As of Sep, 1 of 1 firms rate FBIO a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their FBIO calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
